申请人:Pfizer Inc.
公开号:US20040077650A1
公开(公告)日:2004-04-22
Compounds of Formula (I) that act as cannabinoid receptor ligands and their uses in the treatment of diseases linked to the modulation of the cannabinoid receptors in animals are described herein.
1
本文描述了作为大麻素受体配体的化合物(I)及其在治疗与动物体内大麻素受体调节相关疾病中的用途。